Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bilcare | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Bilcare

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vincent Santa Maria has been appointed president of Bilcare, Inc. Mr. Santa Maria has more than 25 years of experience primarily in pharmaceutical operations and pharmaceutical services, most recently serving as a consultant to the industry.

“Vincent is highly regarded throughout the clinical services industry and brings a wealth of knowledge and experience to Bilcare,” said Mohan Bhandari, chairman and managing director of Bilcare Ltd. “Given his expertise and drive, we are confident that Vincent will be a great asset for business development and provide the necessary leadership as we continue to set new standards of product quality and customer service in what is becoming an increasingly competitive marketplace.”

Prior to serving as a consultant to the pharmaceutical industry, Mr. Santa Maria was president and managing director of Almedica Service Corp. where he oversaw daily operations including manufacturing, business development, project management, quality assurance, finance, risk management, human resources and IT.

Mr. Santa Maria succeeds Steve Jacobs who served as Bilcare president and global chief operating officer for the past two years.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics